Macquarie Group’s Ambrx Biopharma Inc AMAM Stock Holding History

Macquarie Group’s Portfolio AMAM Stock Details AMAM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-300,000	Closed	-$4.27M	–	1965
2023 Q4	$4.27M	Buy	300,000 +50,000	+20%	+$568K	﹤0.01%	1009
2023 Q3	$2.88M	Buy	+250,000	New	+$3.41M	﹤0.01%	1067

Macquarie Group's AMAM Position: Q1 2024 in Review

Macquarie Group sold out of Ambrx Biopharma Inc (AMAM) in Q1 2024, closing a stake of 300,000 shares — an estimated $4.27M sold.

Macquarie Group first reported a position in AMAM in Q3 2023 and held it in 2 quarters. The position peaked at $4.27M in Q4 2023. 0 funds tracked by Wall St. Rank hold AMAM as of Q1 2024.

Macquarie Group reported no remaining Ambrx Biopharma Inc position as of Q1 2024 after selling out during the quarter.
Macquarie Group sold 300,000 Ambrx Biopharma Inc shares in Q1 2024, an estimated $4.27M.
Macquarie Group first reported a position in Ambrx Biopharma Inc in Q3 2023 and held it in 2 quarters.
Macquarie Group's Ambrx Biopharma Inc position peaked at $4.27M in Q4 2023.
0 funds tracked by Wall St. Rank held Ambrx Biopharma Inc as of Q1 2024.

Based on Macquarie Group's 13F filing for Q1 2024, filed 14 May 2024.